In an NBC News story about the reality gap between businesses talking about artificial intelligence (AI) and those that are actually using it, an investment analyst from Oppenheimer said, “There’s not ...
A photo of a CanSino scientist holding a vial of its Ad5-based COVID-19 vaccine. CanSino Biologics began a clinical trial of its Ad5-based COVID-19 vaccine on March 16. Credit: CanSino Biologics ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
In my last post, Artificial Intelligence and the Shape of Reality, I jumped off the deep end and explored an idea that surprised even me as I wrote it—that the high-dimensional space in which large ...